Nucleus Capital (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Berlin
Nucleus Capital is a new venture capital company founded in Germany by Maximilian A. Bade in 2020.
- in 2024, Nucleus Capital announced 90% commitments for a €40 million fund focused on synthetic biology startups in Germany.
Average round investment:4.34M USD
Average number per year:6.4
Distribution:
2025 (4)2024 (3)2023 (7)2022 (10)2021 (8)
Mostly invests in:
Germany (15)
Manufacturing (21)
Germany (15)
Manufacturing (21)
See the entire list
Showing 3 of 32 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Nucleus Capital mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Nucleus Capital
| Name | Criteria | |
|---|---|---|
![]() |
500 Global
100%
|
|
![]() |
DEPO Ventures
100%
|
|
![]() |
Katapult Accelerator
99%
|
|
![]() |
Olivier Bonnet
99%
|
|
![]() |
Sofia Angels Ventures
99%
|
|
![]() |
40Jemz Ventures
99%
|
|
![]() |
Golden Egg Check Capital
99%
|
|
![]() |
Rob Barker
99%
|
|
![]() |
Mustard Seed Maze
99%
|
|
![]() |
Johann Hansmann
99%
|
|
Vosbor
ScienceMachine
Koppie







Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Sweden
Ireland
Spain